Poland Pharmaceutical and Medical Goods Expenditure Share (2024)
Poland's Pharmaceutical and Medical Goods Expenditure Share: 16.7 % of current health expenditure in 2024, -0.8pp YoY. Eurostat (HLTH_SHA11_HC), 2016–2024.
Poland (2024)
16.7
% of current health expenditure
-0.8pp YoY
YoY Change
-0.8pp
percentage points
Trend
down
Series length
9
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2024 | 16.7 | -0.8pp |
| 2023 | 17.5 | -0.6pp |
| 2022 | 18.1 | -2.6pp |
| 2021 | 20.7 | -1pp |
| 2020 | 21.7 | -0.1pp |
| 2019 | 21.8 | -1.1pp |
| 2018 | 22.9 | +0.2pp |
| 2017 | 22.7 | -0.5pp |
| 2016 | 23.2 | n/a |
About this Dataset
Poland recorded 16.7 % of current health expenditure in 2024. The latest change was -0.8pp. Across 2016–2024 the series ranges from 16.7 in 2024 to 23.2 in 2016.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Poland.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Poland. It is published by Eurostat and updated annually.
The most recent observation covers 2024. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2016–2024 (9 observations).
The series peaked at 23.2 % of current health expenditure in 2016 and reached its lowest recorded value of 16.7 in 2024. The latest reading of 16.7 in 2024 represents a change of -0.8pp.